Ortho Clinical Diagnostics to Break Ground On Solar Energy Installation in Raritan

Raritan, NJ (March 25, 2010) – Today, Ortho Clinical Diagnostics, a Johnson & Johnson company, announced that it will break ground for a solar array at its Raritan N.J. headquarters. The 1.69-megawatt array of over 7,300 ground-mounted panels – expected to generate about 2 million kilowatt-hours (kWh) of power per year – will be installed on six acres. The program is expected to decrease green house gas emissions through the production of renewable energy that is equivalent to taking about 270 passenger vehicles off the road per year. The company expects to complete the installation later this year.

“We are committed to operating our business in a manner that responsibly addresses the long-term energy needs of the company and supports the environmental health of our community and our planet,” said Stuart Magloff, Vice President of Operations, Ortho Clinical Diagnostics. “This project will generate about 10 percent of our facility’s energy needs when completed and decrease carbon dioxide emissions by approximately 1,600 metric tons annually.”

Johnson & Johnson set a company-wide goal of reducing its carbon footprint at its facilities nationwide by 7 percent between 1990 and 2010. In addition to the Ortho Clinical Diagnostics Raritan site, Johnson & Johnson has solar power systems planned for 2010 or completed at 20 sites worldwide which together represent an installed capacity of about 13 megawatts. The Ortho Clinical Diagnostics solar panel installation will be among the largest of Johnson & Johnson solar installations.

As of May 2008, Johnson & Johnson was the second-largest corporate user of on?site solar energy in the U.S., according to the World Resources Institute. The company is the nation’s tenth-largest purchaser of renewable energy, according to the EPA Green Power Partnership, and has received six Green Power Leadership Awards from the U.S. Environmental Protection Agency and Department of Energy since 2002.

About Ortho Clinical Diagnostics

Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company, delivers the high-quality in vitro diagnostic products that give healthcare professionals around the world the knowledge they need to make better treatment decisions sooner. The company serves the global transfusion medicine community with donor screening and blood typing products to help ensure every patient receives blood that is safe, the right type and the right unit. Ortho Clinical Diagnostics also brings sophisticated information management, testing technologies, and automation and interpretation tools to clinical laboratories worldwide to help them run more efficiently and improve patient care.  For more information, visit

# # #